Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 101 filers reported holding Y-MABS THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $819,000 | -46.3% | 50,503 | -5.4% | 0.01% | -40.0% |
| Q3 2021 | $1,524,000 | -21.4% | 53,409 | -6.9% | 0.02% | -11.8% |
| Q2 2021 | $1,940,000 | -1.0% | 57,386 | +12.5% | 0.02% | -41.4% |
| Q3 2020 | $1,959,000 | -16.4% | 51,029 | -5.9% | 0.03% | -6.5% |
| Q2 2020 | $2,343,000 | +31.9% | 54,239 | -20.4% | 0.03% | +121.4% |
| Q3 2019 | $1,777,000 | +8.6% | 68,175 | -4.8% | 0.01% | +16.7% |
| Q2 2019 | $1,637,000 | – | 71,575 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 216,916 | $6,191,000 | 3.86% |
| Sofinnova Investments, Inc. | 2,194,278 | $62,625,000 | 3.71% |
| MPM BioImpact LLC | 452,970 | $12,928,000 | 2.00% |
| Soleus Capital Management, L.P. | 265,700 | $7,583,000 | 1.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 452,110 | $12,903,000 | 1.17% |
| ORACLE INVESTMENT MANAGEMENT INC | 315,642 | $9,008,000 | 1.12% |
| First Light Asset Management, LLC | 577,663 | $16,487,000 | 1.09% |
| Lombard Odier Asset Management (Switzerland) SA | 352,839 | $10,070,000 | 0.62% |
| Cormorant Asset Management, LP | 500,000 | $14,270,000 | 0.58% |
| Artal Group S.A. | 400,000 | $11,416,000 | 0.26% |